Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|August 24, 2021
Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic targetClare Gould, Jennifer Lickiss, Yamuna Kankanige, et al.
Cancer Discovery|June 3, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLMin Xia, Liron David, Matt Teater, et al.
Blood|October 23, 2024
CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCLWaleed Alduaij, Aixiang Jiang, Diego Villa, et al.
Blood|August 12, 2024
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2Brett Collinge, Susana Ben-Neriah, Laura K Hilton, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Blood|February 6, 2014
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphomaDavid D W Twa, Fong Chun Chan, Susana Ben-Neriah, et al.
Annals of Hematology|September 27, 2024
Rosai-Dorfman-Destombes disease in adults: a single center experienceEmily Leung, Collin Pryma, Stephen Murphy, et al.
Blood Advances|October 10, 2025
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL MorphologyWaleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Blood Advances|June 10, 2020
Gene expression profiling of gray zone lymphomaClémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, et al.
Pageof 9